Z-0779-2017 Class III Terminated

Recalled by PerkinElmer Health Sciences, Inc. — Waltham, MA

FDA device recall Z-0779-2017 was initiated by PerkinElmer Health Sciences, Inc. on Nov 16, 2016 and is designated Class III. Reason for recall: A DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was… The recall status is terminated (terminated Jul 5, 2017). Affected quantity: 79 kits.

Recall details

Product Type
Devices
Report Date
Dec 28, 2016
Initiation Date
Nov 16, 2016
Termination Date
Jul 5, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
79 kits

Product description

DELFIA hFSH kit. In Vitro Diagnostic for the determination of hFSH in serum

Reason for recall

A DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was observed at an hFSH target concentration of 101 IU/L. The change observed in the serum samples within the range 1.76  67.0 IU/L hFSH averaged -2.9%. The reference range of the assay spans 0.60 to 98.0 IU/L.

Distribution pattern

CA, CO, NY, WA Foreign: Austria, Bolivia, Bosnia , Sweden, Norway, Netherlands, Japan, Great Britain,

Code information

Lot Number: 646091

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0779-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0779-2017. Report a data issue: hello@regdatalab.com.